Clinical Trials Browser

Phase 2/3 × Carcinoma, Hepatocellular × Ipilimumab × Clear all

NCT05665348 2026-03-09

TRIPLET

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis